Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors	Intermediate Trophoblastic Tumor	Recruiting	Phase 1 / Phase 2	2025-04-30		NCT06941766

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dalian Women and Children's Medical Center	3
Gansu Provincial Maternal and Child Health Care Hospital	17
Henan Cancer Hospital	147
Obstetrics & Gynecology Hospital of Fudan University	36
Peking Union Medical College Hospital	417
Shengjing Hospital	111
Sichuan Cancer Hospital and Research Institute	64
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	285
The First Affiliated Hospital of Xiamen University	107

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking Union Medical College Hospital	Beijing	China	201